[ Price : $8.95]
FDA alerts health care providers and facilities on the use of oxygenators in extracorporeal circulation following a recent recall ...[ Price : $8.95]
An FDA advisory committee votes 6 to 0 that data from the Phase 3 CLARITY AD trial verified the clinical benefit of Eisai/Biogens ...[ Price : $8.95]
FDA clears a SurGenTec 510(k) for its TiLink-L Sacroiliac Joint Fusion System.[ Price : $8.95]
FDA says that while drug shortages have declined since 2011, there still are needs to be addressed to help the agency prevent or m...[ Price : $8.95]
FDA publishes a guidance to help IND and NDA sponsors evaluate the drug-drug interaction effects of their investigational drugs on...[ Price : $8.95]
FDA accepts for review a Merck supplemental BLA for Keytruda in combination with standard-of-care chemotherapy for treating patien...[ Price : $8.95]
FDA approves an Avita Medical PMA supplement for use of its Recell System to treat full-thickness skin defects.[ Price : $8.95]
Federal Register notice: FDA determines that Bristol Myers Squibbs Buspar (buspirone HCl) was not withdrawn due to safety or effec...